Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. infectious disease studies
Show results for
Products
Services
Applications

Companies

News
Articles

Refine by
Date

  • Older

Infectious Disease Studies Articles & Analysis

9 news found

CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing

CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing

With this service, CD Genomics empowers researchers to unlock the full potential of their studies with unrivalled precision and efficiency. Harnessing the power of Oxford Nanopore sequencing technology, this revolutionary platform enables real-time analysis of RNA molecules without the need for cumbersome reverse transcription and amplification steps. ...

ByCD Genomics


Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

The company launches the drug-resistant metabolomics research service for oncology research and infectious disease studies regarding drug resistance. Drug therapy is one of the major modalities for cancer treatment. ...

ByCreative Proteomics


Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that three Idylla™ study posters, of which two on the SeptiCyte® RAPID (developed in collaboration with Immunexpress) and one on the Idylla™ SARS-CoV-2 Test (CE-IVD) and Idylla™ SARS-CoV-2/Flu/RSV ...

ByBiocartis NV


Preparing the World for the Next Pandemic | EnGen Bio

Preparing the World for the Next Pandemic | EnGen Bio

As the world still holds its breath for the widespread rollout of COVID-19 vaccines, the experts studying infectious diseases are already shifting their focus to the prevention of the next pandemic. ...

ByEnGen Bio LLC


Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains

Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains

As scientists continue to identify new strains of the SARS-CoV-2 virus, including the B.1.1.7 UK variant that studies suggest is more transmissible, genetic sequencing is being used to track these strains and new ones that are emerging, as well as to trace transmission patterns within communities. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Thermo Fisher Scientific Expands GlobalAccess Sequencing Program

Thermo Fisher Scientific Expands GlobalAccess Sequencing Program

Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2, the expanded program now provides support to labs facing significant constraints as a result of the global pandemic by offering faster access to comprehensive, single-day molecular profiling of tumor tissue on Thermo Fisher's Ion Torrent Genexus System. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Ionicon PTR-TOF instruments deployed for COVID-19 detection in breath

Ionicon PTR-TOF instruments deployed for COVID-19 detection in breath

SARS-CoV-2 currently has the world in its grasp. A quick, non-invasive test to identify an infection would be a tremendous step forward. There is a high probability that this disease can be detected in the exhaled breath but also monitoring the impact of treatment or medication in exhaled breath is highly relevant. IONICON PTR-TOF systems have become the de-facto standard for real-time breath ...

ByIonicon Analytik Ges.m.b.H.


Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program

Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program

To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Deadly Fungal Pathogen Appears to be Developing Drug Resistance

Deadly Fungal Pathogen Appears to be Developing Drug Resistance

Clinical Infectious Diseases recently published a study that discovered azole-resistance markers in 75% of a small group of aspergillosis patients who had not previously been treated with an azole. Although the study group was small, the findings appear to indicate that there is a growing dissemination of drug-resistant strains ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT